Assurance Biosense Receives FDA 510(k) Clearance
Apr.16, 2013 in
News
Assurance Biosense, Inc., a subsidiary of Xhale, Inc., today announced receipt from the U.S. Food and Drug Administration (FDA) of 510(k) clearance to market its Assurance® Alar Sensor for monitoring of oxygen saturation of arterial hemoglobin (SpO2) and pulse rate from the nasal ala of adult and pediatric patients.
Comments Off on Assurance Biosense Receives FDA 510(k) Clearance
